Streetbeat News

Analyst Ratings

MYNZ

Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Mainz Biomed (NASDAQ:MYNZ) and maintained a $9 price target.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 3:38 pm

LUCD

Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Lucid Diagnostics (NASDAQ:LUCD) and maintained a $4 price target.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 3:37 pm

ABNB

Tigress Financial analyst Ivan Feinseth has reiterated a 'Buy' rating on Airbnb (NASDAQ:ABNB) and maintained a price target of $185.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 3:35 pm

AMD

A significant bearish stance has been taken on Advanced Micro Devices (NASDAQ:AMD) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 30% bullish and 69% bearish. The whales have been targeting a price range from $90.0 to $135.0 for AMD over the last 3 months. The current price of AMD is down -1.85% at $106.22. Several financial institutions have given their ratings and price targets for AMD.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 3:31 pm

BAC

A whale investor has taken a bullish stance on Bank of America (NYSE:BAC), with 50% of the investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $25.0 to $40.0 for Bank of America over the last 3 months. The price of BAC is currently down -1.89% at $28.6. Oppenheimer has maintained their Outperform rating on Bank of America, with a price target of $49.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 3:31 pm

MRNA

A whale investor has taken a bearish stance on Moderna (NASDAQ:MRNA), with 66% of the spotted trades being bearish. The trades include 3 puts amounting to $167,472 and 12 calls amounting to $761,200. The whales have been targeting a price range from $90.0 to $135.0 for Moderna over the last 3 months. The price of MRNA is currently up 3.82% at $115.32, and RSI indicators suggest that the stock may be approaching overbought.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 3:30 pm

MSGE

SPHR

Madison Square Garden Entertainment Corp (MSGE) reported upbeat earnings but disappointing sales for its fiscal fourth quarter. BofA Securities analyst Peter Henderson initiated coverage of MSGE with a Buy rating and a price target of $41, predicting a 30% upside to the stock. Henderson believes MSGE can achieve its goals of improving venue utilization, driving more premium hospitality, and increasing sponsorship by monetizing new verticals including insurance.

Portfolio Pulse from Priya Nigam

August 22, 2023 | 3:26 pm

JD

JD.com (NASDAQ:JD) has seen unusual options activity, with a significant number of investors taking a bullish stance. Of the 17 strange trades detected, 64% were bullish and 35% bearish. The majority of trades were puts, totaling $1,128,096, with calls totaling $131,109. Whales have been targeting a price range of $27.5 to $50.0 for JD.com over the last 3 months. The current price of JD is $33.09, down 0.39%. Analysts from Mizuho, JP Morgan, Citigroup, and B of A Securities have maintained their ratings on JD.com, with price targets ranging from $40 to $64.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 3:15 pm

YOU

The Street.com has recommended Clear Secure as a buy in their Action Alerts Plus segment.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 3:13 pm

BLDE

Citigroup analyst Itay Michaeli has maintained a 'Buy' rating on Blade Air Mobility (NASDAQ:BLDE) but lowered the price target from $9 to $8.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 3:04 pm